Searchable abstracts of presentations at key conferences in endocrinology

ea0022p240 | Clinical case reports and clinical practice | ECE2010

Synergic effect of Cabergoline in acromegaly treated with somatostatin analogues. Report of two cases

Paja Miguel , Perez-Yeboles Josu , Lizarraga Aitzol , Moreno Cristina , Isusquiza Ana , Elorza J Ramon

Current treatment for acromegaly includes dopamine agonists (DA), somatostatin receptor ligands (SRL) and GH receptor antagonists (GHRA). DA in monotherapy, is less than 10% effective achieving control of the disease, and its efficacy in addition to ongoing SRL is less studied, without obvious determining factors of response. We report 2 operated patients with incomplete response to SRL and to whom Cabergoline addition led to disease control.Case 1: A ma...